Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 in Uganda: Predicting the impact of the disease and public health response on disease burden

View ORCID ProfileDavid Bell, Kristian Schultz Hansen, Agnes N. Kiragga, Andrew Kambugu, John Kissa, Anthony K. Mbonye
doi: https://doi.org/10.1101/2020.05.14.20102202
David Bell
1Independent Consultant, Issaquah, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Bell
  • For correspondence: bell00david@gmail.com
Kristian Schultz Hansen
2Department of Public Health and Centre for Health Economics and Policy, University of Copenhagen, Øster Farimagsgade 5A, 1014 Copenhagen K, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnes N. Kiragga
3Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Kambugu
3Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Kissa
4Uganda Ministry of Health – Division of Health Information, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony K. Mbonye
5School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective COVID-19 transmission and the ‘lock-down’ response are now established in sub-Saharan Africa, including Uganda. Population age distributions and prior morbidities differ markedly in these countries from those where large outbreaks have become established previously. We determined to predict likely impact of COVID-19 and the response on the Ugandan population, measure and compare these appropriately, to understand whether the benefits of the response could be outweighed by the costs.

Design and setting We applied age-based COVID-19 mortality data from China to the population structures of Uganda and countries with previously established outbreaks, comparing theoretical mortality and disability-adjusted life years (DALYs) lost. Based on recent Uganda health system data and on theoretical scenarios of program deterioration, we predicted potential mortality and DALYs lost for HIV/AIDS, malaria and maternal.

Main outcome measures Disability-adjusted life years (DALYs) lost, mortality.

Results Based on population age structure alone, Uganda is predicted to have a relatively low COVID-19 burden, with 12% of the mortality and 19% of the lost DALYs predicted for equivalent transmission in the Italian population. Scenarios of ‘lockdown’ impact predict comparable or higher burdens from HIV or malaria alone to that of an extensive COVID-19 outbreak. Emerging disease data presented from Uganda, including HIV case finding and maternal mortality, suggest early signs that such deterioration could be occurring.

Conclusions The results indicate that COVID-19 impact on Uganda may be relatively light, while there is a high risk of a significant negative impact on other disease burden if the lockdown response to COVID-19 is prolonged. The results are likely to extend to other sub-Saharan populations, underlining the importance of tailoring COVID-19 responses according to population structure and potential disease vulnerabilities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data on which the work is based are publicly available (referenced) while calculations are available from the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 in Uganda: Predicting the impact of the disease and public health response on disease burden
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 in Uganda: Predicting the impact of the disease and public health response on disease burden
David Bell, Kristian Schultz Hansen, Agnes N. Kiragga, Andrew Kambugu, John Kissa, Anthony K. Mbonye
medRxiv 2020.05.14.20102202; doi: https://doi.org/10.1101/2020.05.14.20102202
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
COVID-19 in Uganda: Predicting the impact of the disease and public health response on disease burden
David Bell, Kristian Schultz Hansen, Agnes N. Kiragga, Andrew Kambugu, John Kissa, Anthony K. Mbonye
medRxiv 2020.05.14.20102202; doi: https://doi.org/10.1101/2020.05.14.20102202

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (412)
  • Dentistry and Oral Medicine (69)
  • Dermatology (47)
  • Emergency Medicine (142)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4843)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (626)
  • Health Policy (318)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5326)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (93)
  • Medical Ethics (25)
  • Nephrology (75)
  • Neurology (685)
  • Nursing (42)
  • Nutrition (114)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (205)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (778)
  • Public and Global Health (1810)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)